| Real-World Study Comparing PCSK9 Monoclonal Antibody With Cholesterol Absorption Inhibitors in Patients With ASCVD for Secondary Prevention | Atorvastatin, Fluvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin, Pitavastatin | — | Active, not recruiting | Xin Li | Nov 16, 2026 |
| An Evaluation of the Potential for VH4011499 Drug-drug-interactions | Rosuvastatin, Pitavastatin | Phase 1 | Not yet recruiting | ViiV Healthcare | Nov 16, 2026 |
| Drug-coated Balloon Angioplasty For Ischemic Stroke Within 30 Days Caused By Intracranial Arterial Stenosis ( BASIS-2 ) | Atorvastatin | Not applicable | Not yet recruiting | Beijing Tiantan Hospital | Nov 12, 2026 |
| A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients | Rosuvastatin | Phase 3 | Not yet recruiting | AstraZeneca | Nov 12, 2026 |
| Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer | Rosuvastatin | Phase 1 | Not yet recruiting | Jiangsu Simcere Pharmaceutical Co., Ltd. | Nov 3, 2026 |
| Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. | Atorvastatin | Phase 3 | Not yet recruiting | First Affiliated Hospital of Wannan Medical College | Nov 2, 2026 |
| Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease | Atorvastatin, Rosuvastatin | Phase 4 | Not yet recruiting | Rehman Medical Institute - RMI | Nov 2, 2026 |
| A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease | Atorvastatin, Fluvastatin, Pravastatin, Simvastatin | Phase 2 | Active, not recruiting | Beijing University of Chinese Medicine | Oct 30, 2026 |
| Clinical Evaluation of the Safety and Efficacy of "Buyan Huan Wu Tang" Combined With Atorvastatin in the Treatment of Atypical Pneumonia | Atorvastatin | Early phase 1 | Enrolling by invitation | The First Affiliated Hospital with Nanjing Medical University | Oct 30, 2026 |
| Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease. | Atorvastatin | Early phase 1 | Enrolling by invitation | The First Affiliated Hospital with Nanjing Medical University | Oct 26, 2026 |
| Comparing Inclisiran Versus Statin for Primary Aldosteronism | Atorvastatin, Fluvastatin, Lovastatin, Simvastatin, Pitavastatin | Not applicable | Recruiting | Third Military Medical University | Oct 21, 2026 |
| A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult Subjects | Rosuvastatin | Phase 1 | Recruiting | Basilea Pharmaceutica | Oct 19, 2026 |
| A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults | Rosuvastatin | Phase 1 | Not yet recruiting | InventisBio Co., Ltd | Oct 15, 2026 |
| Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis | Rosuvastatin, Pitavastatin | Phase 4 | Not yet recruiting | Yonsei University | Oct 13, 2026 |
| VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma | Lovastatin, Simvastatin | Phase 2 | Recruiting | Inova Health Care Services | Sep 21, 2026 |
| A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults | Pitavastatin | Phase 1 | Not yet recruiting | Huons Co., Ltd. | Aug 25, 2026 |
| Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure | Lovastatin, Simvastatin | Phase 2 | Not yet recruiting | University of Colorado, Denver | Aug 21, 2026 |
| Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa | Pitavastatin | Phase 1 | Recruiting | Kyushu University | Aug 19, 2026 |
| Study of ECC4703 With Sulfasalazine and Pitavastatin | Pitavastatin | Phase 1 | Recruiting | Eccogene | Jul 24, 2026 |
| Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer | Simvastatin | Phase 2 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | Jul 22, 2026 |
| Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma | Lovastatin, Pravastatin, Simvastatin | Not applicable | Recruiting | University of Colorado, Denver | Jul 15, 2026 |
| New Topical Treatment in Patchy Alopecia Areata | Lovastatin, Simvastatin | Not applicable | Not yet recruiting | Sohag University | Jul 10, 2026 |
| Topical 2% Simvastatin for Xanthelasma Palpebrarum | Lovastatin | Phase 2 | Not yet recruiting | Klira Skin | Jun 23, 2026 |
| RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial | Lovastatin | Phase 2 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | Jun 4, 2026 |
| Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention | Pitavastatin | Not applicable | Not yet recruiting | Samsung Medical Center | Jun 4, 2026 |
| Novel Treatment of Radiation Associated Dysphagia With Statins | Pravastatin | Phase 2 | Recruiting | Peter MacCallum Cancer Centre, Australia | Oct 20, 2025 |
| Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial) | Pravastatin | Phase 2 | Recruiting | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Aug 1, 2025 |
| Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose) | Pravastatin | Phase 2 | Recruiting | M.D. Anderson Cancer Center | Apr 6, 2025 |
| Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial | Pravastatin | Phase 4 | Not yet recruiting | Tor Biering-Sørensen | Mar 4, 2025 |
| Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants | Fluvastatin | Phase 1 | Not yet recruiting | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Feb 17, 2025 |
| Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study | Fluvastatin, Pravastatin | — | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Jan 21, 2025 |
| StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial | Fluvastatin | Phase 4 | Not yet recruiting | Prof. dr. Nathalie van der Velde | Jan 21, 2025 |
| A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients | Fluvastatin | Phase 1 / Phase 2 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | Nov 7, 2024 |
| LATAM LOWERS LDL-C | Fluvastatin | Phase 4 | Recruiting | Novartis Pharmaceuticals | Jul 15, 2024 |